Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
ONC Transcript
BeOne Medicines AG (ONC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
BeOne Medicines AG (ONC) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call highlights strong financial performance with significant revenue growth, improved margins, and increased net income. The Q&A reveals confidence in product launches, especially BRUKINSA, and stable pricing. Despite some uncertainties in competitive dynamics and efficacy benchmarks, the overall sentiment is optimistic, supported by strategic advancements and strong guidance. The positive financial results and optimistic outlook suggest a likely stock price increase in the coming weeks.
BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call showed strong financial performance with notable revenue and margin growth. The Q&A highlighted BRUKINSA's competitive edge and positive market reaction to Sonro. Despite limited details on pricing and immunology strategy, the overall sentiment remains positive due to strong earnings, optimistic guidance, and a solid pipeline. The lack of market cap data suggests a moderate impact, leading to a positive stock price movement prediction.
BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
